Jane Street
STLN

Jane Street’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Jane Street’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Sell
424,894
-378,421
-47% -$1.16M ﹤0.01% 5927
2025
Q4 		$2.86M Buy
803,315
+678,427
+543% +$2.52M ﹤0.01% 4128
2025
Q3 		$436K Buy
+124,888
New +$428K ﹤0.01% 8145
2025
Q1 		– Sell
-127,659
Closed -$39.4K – 10613
2024
Q4 		$39.4K Buy
127,659
+109,769
+614% +$28.5K ﹤0.01% 9030
2024
Q3 		$5.85K Sell
17,890
-13,721
-43% -$5.68K ﹤0.01% 9391
2024
Q2 		$14.5K Buy
+31,611
New +$27K ﹤0.01% 9070
2024
Q1 		– Sell
-28,187
Closed -$57.5K – 10083
2023
Q4 		$57.5K Buy
+28,187
New +$48.9K ﹤0.01% 8750
2023
Q3 		– Sell
-22,974
Closed -$12.6K – 9392
2023
Q2 		$12.6K Sell
22,974
-24,153
-51% -$12.8K ﹤0.01% 8409
2023
Q1 		$31.9K Buy
+47,127
New +$60.1K ﹤0.01% 8561

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's STLN Position: Q1 2026 in Review

Jane Street reduced its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 47% in Q1 2026, selling an estimated $1.16M and leaving 424,894 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #5927.

Jane Street first reported a position in STLN in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.86M in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Jane Street held 424,894 shares of Starling Oncology Institute, Inc. Common Stock worth $1.3M as of Q1 2026.
  • Jane Street sold 378,421 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $1.16M.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5927 holding.
  • Jane Street first reported a position in Starling Oncology Institute, Inc. Common Stock in Q1 2023 and has held it in 9 quarters since.
  • Jane Street's Starling Oncology Institute, Inc. Common Stock position peaked at $2.86M in Q4 2025.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.